How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

United States Immigration and Customs Enforcement is leveraging Palantir’s generative artificial intelligence tools to sort and summarize immigration enforcement tips from its public submission form, ...

CloudX – a startup co-founded by the guys who co-founded MoPub and MAX – is using LLMs agents, “intelligent monetization” and a trusted execution environment to make the mobile ad stack behave more ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Mr. Shirky, a vice provost at New York University, has been helping faculty members and students adapt to digital tools since 2015. Back in 2023, when ChatGPT was still new, a professor friend had a ...